Clinical Trial Update: Intravenous Dexamethasone for Ropivacaine Axillary Block [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating intravenous dexamethasone for ropivacaine axillary block in postoperative pain management has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia Related Pain Management
• Forearm Injuries
• Postoperative Pain

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Ropivacaine (Ropivacaine)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Postoperative Pain, Anesthesia | Phase 3 | Status: COMPLETED